Rimsys launches Rimsys Intel, a community-driven platform granting free access to global regulatory intelligence, in line with its mission to broaden the availability of life-saving medical technologies. CEO James Gianoutsos emphasizes Rimsys' commitment to accessibility, enabling medtech teams to make informed market access decisions swiftly. To ensure the accuracy of Rimsys Intel amid evolving regulations, Rimsys collaborates with RAPS Regulatory Affairs Certificate (RAC) holders, offering them opportunities to earn recertification credits while contributing to data quality. This partnership benefits both parties, empowering the medtech community with validated regulatory insights and supporting the professional development of RAC holders. Rimsys Intel aims to democratize access to regulatory intelligence, catering to stakeholders ranging from individual entrepreneurs to large-scale medtech enterprises. While currently in beta, interested users can join the waitlist for early access, with plans for full availability later this year.
Read More - https://www.techdogs.com/tech-news/business-wire/rimsys-launches-community-driven-regulatory-intelligence
No comments yet